Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Sjoukje F. Oosting"'
Autor:
Marleen Woltman van Iersel, Frederike Bensch, Thomas C. Kwee, Andor W. J. M. Glaudemans, Adrienne H. Brouwers, Suzanne C van Es, Sjoukje F. Oosting, John H. Maduro, Sjoerd G. Elias, Carolina P. Schröder, Ton Velleman, Elisabeth G.E. de Vries
Publikováno v:
Journal of Nuclear Medicine, 62(2), 177-183. SOC NUCLEAR MEDICINE INC
Rationale: Whether assessment of potential bone lesions in metastatic breast cancer (MBC) by means of 18F-fluorodeoxyglucose (FDG)-PET instead of 99mTechnetium (99mTc) bone scintigraphy (BS) supports clinically relevant changes in MBC management, is
Autor:
Roel J H M Steenbakkers, Johannes A. Langendijk, Arjen van der Schaaf, Gyorgy B. Halmos, Tineke W.H. Meijer, Lisa Van den Bosch, E. Oldehinkel, Max J. H. Witjes, Johanna G M van den Hoek, Sjoukje F. Oosting, Hans Paul van der Laan
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics, 111(2), 456-467. ELSEVIER SCIENCE INC
Purpose: Radiation therapy is an effective but burdensome treatment for head and neck cancer (HNC). We aimed to characterize the severity and time pattern of patient-reported symptoms and quality of life in a large cohort of patients with HNC treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328e545e22645a0beacfc6a9bceab8cf
https://research.rug.nl/en/publications/587e50dc-105e-44cc-b971-4fdaf8777629
https://research.rug.nl/en/publications/587e50dc-105e-44cc-b971-4fdaf8777629
Autor:
L. Sommers, Johannes A. Langendijk, Lisanne V. van Dijk, Sjoukje F. Oosting, Johanna G. M. Vemer-van den Hoek, Henk P. Bijl, Roel J H M Steenbakkers, Tian-Tian Zhai, Nanna M. Sijtsema, Walter Noordzij, Gyorgy B. Halmos, Max J. H. Witjes, Arjen van der Schaaf
Publikováno v:
Radiotherapy and Oncology, 146, 58-65. ELSEVIER IRELAND LTD
Background and purpose: To develop and validate a pre-treatment radiomics-based prediction model to identify pathological lymph nodes (pLNs) at risk of failures after definitive radiotherapy in head and neck squamous cell carcinoma patients. Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff02737bdaacff322e264e1032e6610
https://research.rug.nl/en/publications/aa08e02b-35e1-48c6-8015-009d563291ec
https://research.rug.nl/en/publications/aa08e02b-35e1-48c6-8015-009d563291ec
Autor:
Ellen Kapiteijn, Thera P. Links, Jan Willem B. de Groot, Sjoukje F. Oosting, Annika M A Berends, Anouk N A van der Horst-Schrivers
Publikováno v:
ACTA ONCOLOGICA, 59(6), 726-729. Taylor & Francis Ltd
Over the last years, an increasing number of tyrosine kinase inhibitors (TKIs) targeting specific receptors have been approved for a large number of indications, in particular many cancers [1].Thei...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf2b54a5d7d198b6f89d624df16e429
https://hdl.handle.net/1887/3184764
https://hdl.handle.net/1887/3184764
Autor:
Z. Lin, Charlotte L. Brouwer, Max J. H. Witjes, Lisanne V. van Dijk, Roel J H M Steenbakkers, Johannes A. Langendijk, Tian-Tian Zhai, Cássia O. Ribeiro, Nanna M. Sijtsema, Gyorgy B. Halmos, Bao-Tian Huang, Sjoukje F. Oosting
Publikováno v:
Radiotherapy and Oncology, 124(2), 256-262. ELSEVIER IRELAND LTD
Purpose: To develop and validate prediction models of overall survival (OS) for head and neck cancer (HNC) patients based on image biomarkers (IBMs) of the primary tumor and positive lymph nodes (Ln) in combination with clinical parameters.Material a
Autor:
Erik J van Helden, Sjoerd G. Elias, Henk M.W. Verheul, Elisabeth G.E. de Vries, Suzanne C van Es, Astrid Aplonia Maria Van Der Veldt, Sarah R. Verhoeff, Erik H.J.G. Aarntzen, Sjoukje F. Oosting, Winette T. A. van der Graaf, Sandra Heskamp, Otto S. Hoekstra, Otto C. Boerman, Lindsay Angus, Wim J.G. Oyen, Carla M.L. van Herpen, Thomas C. Kwee, Adrienne H. Brouwers, Eline Boon
Publikováno v:
Verhoeff, S R, van Es, S C, Boon, E, van Helden, E, Angus, L, Elias, S G, Oosting, S F, Aarntzen, E H, Brouwers, A H, Kwee, T C, Heskamp, S, Hoekstra, O S, Verheul, H, van der Veldt, A A M, de Vries, E G E, Boerman, O C, van der Graaf, W T A, Oyen, W J G & van Herpen, C M L 2019, ' Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 9, pp. 1931-1939 . https://doi.org/10.1007/s00259-019-04358-9
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46, 1931-1939
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 46, 9, pp. 1931-1939
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46, 1931-1939
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 46, 9, pp. 1931-1939
Purpose The main objective of this preliminary analysis of the IMaging PAtients for Cancer drug selecTion (IMPACT)-renal cell cancer (RCC) study is to evaluate the lesion detection of baseline contrast-enhanced CT, [89Zr]Zr-DFO-girentuximab-PET/CT an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18fa35968023bca2a3e9f115930859d3
https://dspace.library.uu.nl/handle/1874/389954
https://dspace.library.uu.nl/handle/1874/389954
Autor:
Alfons H. H. Bongaerts, Wim J. Sluiter, Elisabeth G.E. de Vries, Sophie J. van Asselt, Johan R. de Jong, Thera P. Links, Bernard A. Zonnenberg, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers, Sjoukje F. Oosting, Julia D.J. Steinberg, Annemiek M E Walenkamp, Eelco W. Hoving, Anouk N A van der Horst-Schrivers
Publikováno v:
Journal of Nuclear Medicine, 57(8), 1244-1250. SOC NUCLEAR MEDICINE INC
Patients with von Hippel-Lindau disease (VHL) are at risk to develop multiple tumors. The growth of lesions is unpredictable, and regular surveillance is critical for early treatment to control local damage. Vascular endothelial growth factor A (VEGF
Autor:
de Igle Jan Jong, Geke A. P. Hospers, Anna M. Leliveld, Jourik A. Gietema, E.G.E. de Vries, Sjoukje F. Oosting, R R H van den Brom, van Suzanne Es
Publikováno v:
Cancer Treatment Reviews. 46:63-72
The number of elderly patients with renal cell carcinoma is rising. Elderly patients differ from their younger counterparts in, among others, higher incidence of comorbidity and reduced organ function. Age influences outcome of surgery, and therefore
Autor:
Phil W. Koken, Hendrik P. Bijl, C. René Leemans, Ben J. Slotman, O. Chouvalova, Miranda E.M.C. Christianen, Irma M. Verdonck-de Leeuw, Sjoukje F. Oosting, Johannes A. Langendijk, Jan L. N. Roodenburg, Bernard F. A. M. van der Laan, Patricia Doornaert, Roel J H M Steenbakkers
Publikováno v:
Radiotherapy and Oncology, 117(1), 139-144. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 117(1), 139-144. Elsevier Ireland Ltd
Christianen, M E M C, Verdonck-de Leeuw, I M, Doornaert, P, Chouvalova, O, Steenbakkers, R J H M, Koken, P W, Leemans, C R, Oosting, S F, Roodenburg, J L N, van Laan, B F A M, Slotman, B J, Bijl, H P & Langendijk, J A 2015, ' Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation. ', Radiotherapy and Oncology, vol. 117, no. 1, pp. 139-144 . https://doi.org/10.1016/j.radonc.2015.07.042
Radiotherapy and Oncology, 117(1), 139-144. Elsevier Ireland Ltd
Christianen, M E M C, Verdonck-de Leeuw, I M, Doornaert, P, Chouvalova, O, Steenbakkers, R J H M, Koken, P W, Leemans, C R, Oosting, S F, Roodenburg, J L N, van Laan, B F A M, Slotman, B J, Bijl, H P & Langendijk, J A 2015, ' Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation. ', Radiotherapy and Oncology, vol. 117, no. 1, pp. 139-144 . https://doi.org/10.1016/j.radonc.2015.07.042
Objectives: To identify patterns of long-term, radiation-induced swallowing dysfunction after definitive radiotherapy with or without chemotherapy (RT or CHRT) and to determine which factors may explain these patterns over time.Material and methods:
Autor:
A. Gawryszuk, Hans Paul van der Laan, Hendrik P. Bijl, Jan L. N. Roodenburg, Johannes A. Langendijk, Johanna G. M. Vemer-van den Hoek, K. Wopken, Arjen van der Schaaf, Bernard F. A. M. van der Laan, Sjoukje F. Oosting, Roel J H M Steenbakkers, O. Chouvalova
Publikováno v:
Radiotherapy and Oncology, 115(1), 56-62. ELSEVIER IRELAND LTD
PURPOSE: To determine if acute symptoms during definitive radiotherapy (RT) or chemoradiation (CHRT) are prognostic factors for late dysphagia in head and neck cancer (HNC).MATERIAL AND METHODS: This prospective cohort study consisted of 260 HNC pati